{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T22:52:54Z","timestamp":1785451974178,"version":"3.56.0"},"reference-count":22,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"unspecified","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Resp Res"],"accepted":{"date-parts":[[2025,12,7]]},"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      The prevalence of infection with non-tuberculous mycobacteria (NTM) has been increasing in people with cystic fibrosis (pwCF) over the past 30 years. Emerging reports of beneficial effects of\n                      <jats:italic>CFTR<\/jats:italic>\n                      modulators, particularly elexacaftor\/tezacaftor\/ivacaftor (ETI), on the rates of NTM acquisition and persistence are encouraging. In this observational study, we evaluate the impact of the introduction of ETI on the prevalence of NTM infection within a cohort of pwCF living in sub-tropical Queensland, Australia.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We examined the impact of ETI introduction on rates of NTM isolation in pwCF attending an adult CF centre and two large regional clinics providing CF care. Data on NTM infection were collected for a minimum of 2\u2009years pre- and post-initiation of ETI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In total, 271 (84.2%) were commenced on ETI with 33 (12.2%) of these pwCF isolating an NTM species on one or more occasion. The number of pwCF isolating\n                      <jats:italic>Mycobacterium abscessus<\/jats:italic>\n                      (Mabs) remained static across the 4-year period of analysis. However, there was a trend towards declining numbers of pwCF isolating either\n                      <jats:italic>Mycobacterium intracellulare<\/jats:italic>\n                      or other NTM species across the surveillance period.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      ETI therapy was not associated with reduced rates of NTM isolation from sputum over the first 2 years of treatment. However, at a species level, two distinct patterns of change were seen with a trend towards a reduction in the isolation of\n                      <jats:italic>M. intracellulare<\/jats:italic>\n                      , while the rates of Mabs isolation remained unchanged. The reasons for this remain unclear at present but highlight the need for ongoing vigilance with screening for NTM in the setting of ETI therapy.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjresp-2025-003204","type":"journal-article","created":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T09:30:15Z","timestamp":1766655015000},"page":"e003204","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Non-tuberculous mycobacterial infection in cystic fibrosis before and after initiation of elexacaftor\/tezacaftor\/ivacaftor: now is not the time to lower the guard"],"prefix":"10.1136","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9669-0805","authenticated-orcid":false,"given":"Ieuan Edward Shepherd","family":"Evans","sequence":"first","affiliation":[{"name":"Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia"},{"name":"Department of Thoracic Medicine, The Prince Charles Hospital, Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Thoracic Medicine, The Prince Charles Hospital, Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Henderson","sequence":"additional","affiliation":[{"name":"Department of Thoracic Medicine, The Prince Charles Hospital, Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Riddles","sequence":"additional","affiliation":[{"name":"Department of Thoracic Medicine, The Prince Charles Hospital, Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Masel","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia"},{"name":"Department of Thoracic Medicine, The Prince Charles Hospital, Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Moore","sequence":"additional","affiliation":[{"name":"Department of Thoracic Medicine, The Prince Charles Hospital, Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J","family":"Burke","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia"},{"name":"Department of Thoracic Medicine, The Prince Charles Hospital, Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel M","family":"Thomson","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia"},{"name":"Department of Thoracic Medicine, The Prince Charles Hospital, Brisbane, Queensland, Australia"},{"name":"Gallipoli Medical Research, Greenslopes Private Hospital, Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W","family":"Reid","sequence":"additional","affiliation":[{"name":"Department of Thoracic Medicine, The Prince Charles Hospital, Brisbane, Queensland, Australia"},{"name":"Lung Inflammation & Infection, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,12,25]]},"reference":[{"key":"2026010701525059000_12.1.e003204.1","first-page":"272","article-title":"Nontuberculous mycobacterial pulmonary disease in cystic fibrosis","volume":"11","author":"Olivier","year":"1996","journal-title":"Semin Respir Infect"},{"key":"2026010701525059000_12.1.e003204.2","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-023-08468-6","article-title":"Incidence of nontuberculous mycobacteria infections among persons with cystic fibrosis in the United States (2010-2019)","volume":"23","author":"Marshall","year":"2023","journal-title":"BMC Infect Dis"},{"key":"2026010701525059000_12.1.e003204.3","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00336-2022","article-title":"Global burden of nontuberculous mycobacteria in the cystic fibrosis population: a systematic review and meta-analysis","volume":"9","author":"Prieto","year":"2023","journal-title":"ERJ Open Res"},{"key":"2026010701525059000_12.1.e003204.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2015.09.007"},{"key":"2026010701525059000_12.1.e003204.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2009.12.001"},{"key":"2026010701525059000_12.1.e003204.6","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jctube.2017.08.002","article-title":"Mycobacterium abscessus disease in lung transplant recipients: Diagnosis and management","volume":"9","author":"Chandrashekaran","year":"2017","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"key":"2026010701525059000_12.1.e003204.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2023.05.003"},{"key":"2026010701525059000_12.1.e003204.8","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s40506-016-0092-6","article-title":"Nontuberculous Mycobacteria in Cystic Fibrosis","volume":"8","author":"Skolnik","year":"2016","journal-title":"Curr Treat Options Infect Dis"},{"key":"2026010701525059000_12.1.e003204.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2022.06.007"},{"key":"2026010701525059000_12.1.e003204.10","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.00519-24","article-title":"Persistence and evolution of Pseudomonas aeruginosa following initiation of highly effective modulator therapy in cystic fibrosis","volume":"15","author":"Armbruster","year":"2024","journal-title":"MBio"},{"key":"2026010701525059000_12.1.e003204.11","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jcf.2023.03.021","article-title":"Eradication of Mycobacterium abscessus infection in cystic fibrosis with initiation of Elexacaftor\/Tezacaftor\/Ivacaftor","volume":"23","author":"McParland","year":"2024","journal-title":"J Cyst Fibros"},{"key":"2026010701525059000_12.1.e003204.12","doi-asserted-by":"crossref","first-page":"139796","DOI":"10.1016\/j.scitotenv.2020.139796","article-title":"Influence of climate variables on the rising incidence of nontuberculous mycobacterial (NTM) infections in Queensland, Australia 2001\u20132016","volume":"740","author":"Thomson","year":"2020","journal-title":"Science of The Total Environment"},{"key":"2026010701525059000_12.1.e003204.13","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.57.3.212"},{"key":"2026010701525059000_12.1.e003204.14","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.jcf.2024.05.008","article-title":"Clinical and radiological improvement of cavitary Mycobacteroides abscessus disease in cystic fibrosis following initiation of elexacaftor\/tezacaftor\/ivacaftor","volume":"23","author":"Gavey","year":"2024","journal-title":"J Cyst Fibros"},{"key":"2026010701525059000_12.1.e003204.15","doi-asserted-by":"crossref","DOI":"10.1080\/20018525.2025.2458341","article-title":"The complexities of elexacaftor\/tezacaftor\/ivacaftor therapeutic drug monitoring in a person with cystic fibrosis and Mycobacterium abscessus pulmonary disease","volume":"12","author":"Mou","year":"2025","journal-title":"Eur Clin Respir J"},{"key":"2026010701525059000_12.1.e003204.16","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201404-184OC"},{"key":"2026010701525059000_12.1.e003204.17","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1164\/rccm.202409-1824OC","article-title":"Infection by Clonally Related Mycobacterium abscessus Isolates: The Role of Drinking Water","volume":"211","author":"Thomson","year":"2025","journal-title":"Am J Respir Crit Care Med"},{"key":"2026010701525059000_12.1.e003204.18","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciq237"},{"key":"2026010701525059000_12.1.e003204.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2024.07.016"},{"key":"2026010701525059000_12.1.e003204.20","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200604-571ST"},{"key":"2026010701525059000_12.1.e003204.21","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2016-209729"},{"key":"2026010701525059000_12.1.e003204.22","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa241"}],"container-title":["BMJ Open Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjresp-2025-003204","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T09:54:33Z","timestamp":1767779673000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopenrespres.bmj.com\/lookup\/doi\/10.1136\/bmjresp-2025-003204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12,25]]},"published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10.1136\/bmjresp-2025-003204"],"URL":"https:\/\/doi.org\/10.1136\/bmjresp-2025-003204","relation":{},"ISSN":["2052-4439"],"issn-type":[{"value":"2052-4439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12]]}}}